Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-141.43%
operating margin TTM
-149.01%
revenue TTM
7.13 Billion
revenue per share TTM
17.98$
valuation ratios | |
|---|---|
| pe ratio | -16.87 |
| peg ratio | 2.00 |
| price to book ratio | 7.89 |
| price to sales ratio | 23.98 |
| enterprise value multiple | -19.04 |
| price fair value | 7.89 |
profitability ratios | |
|---|---|
| gross profit margin | -12.57% |
| operating profit margin | -149.01% |
| pretax profit margin | -138.55% |
| net profit margin | -141.43% |
| return on assets | -28.75% |
| return on equity | -39.2% |
| return on capital employed | -39.4% |
liquidity ratios | |
|---|---|
| current ratio | 2.29 |
| quick ratio | 2.18 |
| cash ratio | 0.68 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 40.75 |
| operating cycle | 57.62 |
| days of payables outstanding | 24.30 |
| cash conversion cycle | 33.32 |
| receivables turnover | 21.63 |
| payables turnover | 15.02 |
| inventory turnover | 8.96 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.12 |
| debt equity ratio | 0.19 |
| long term debt to capitalization | 0.08 |
| total debt to capitalization | 0.16 |
| interest coverage | -132.80 |
| cash flow to debt ratio | -0.82 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.09 |
| cash per share | 12.97 |
| operating cash flow per share | -2.66 |
| free cash flow operating cash flow ratio | 1.16 |
| cash flow coverage ratios | -0.82 |
| short term coverage ratios | -20.23 |
| capital expenditure coverage ratio | -6.15 |
Frequently Asked Questions
When was the last time Moderna, Inc. (NASDAQ:MRNA) reported earnings?
Moderna, Inc. (MRNA) published its most recent earnings results on 31-07-2026.
What is Moderna, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Moderna, Inc. (NASDAQ:MRNA)'s trailing twelve months ROE is -39.2%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Moderna, Inc. (MRNA) currently has a ROA of -28.75%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MRNA's net profit margin stand at?
MRNA reported a profit margin of -141.43% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MRNA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.29 in the most recent quarter. The quick ratio stood at 2.18, with a Debt/Eq ratio of 0.19.